Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01529580 · ClinicalTrials.gov registry record · NA
School-Age Children With Autism With Limited Expressive Language Skills
A NA study, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT01529580 is a NA study that has completed, run by Hugo W. Moser Research Institute at Kennedy Krieger. The registered enrollment target is 13 participants.
The verdict
NCT01529580, a NA study, has completed, sponsored by Hugo W. Moser Research Institute at Kennedy Krieger.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This project will address a major challenge to the field of autism research: improving expressive communication in children with autism who have reached school age but have not acquired functional spoken language (non-verbal school aged children with autism; NVSACA). Fifteen children who completed the RO1 ICAN intervention (NCT01018407) at the Kennedy Krieger site and follow-up testing but continue to have minimal functional spoken language will be participants in this study. After eligibility is established, participants will be randomly assigned to a baseline duration of one week, two weeks or three weeks before the start of active treatment. Once the baseline duration is completed, participants begin active treatment one hour of intervention three days per week in the participants' school setting. In month 2, weekly teacher trainings begin. In month 5, weekly parent trainings begin to improve the child's generalization of skills and teach parents the strategies implemented in their child's treatment. Post-baseline and post-treatment assessments will be completed in the lab at a time that is convenient for the participants' families.
Interventions
- BEHAVIORAL Non-Verbal School Aged Children with Autism (NVSACA) Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01529580
The ClinicalTrials.gov registry entry for NCT01529580 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Verbal School Aged Children with Autism (NVSACA) Intervention is the first listed.
NCT01529580 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01529580 about?
NCT01529580 is a clinical study titled "School-Age Children With Autism With Limited Expressive Language Skills". This project will address a major challenge to the field of autism research: improving expressive communication in children with autism who have reached school age but have not acquired functional spoken language (non-verbal school aged children with autism; NVSACA). Fifteen children who completed ...
What is the current status of trial NCT01529580?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2012-01. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01529580?
The interventions under investigation include: Non-Verbal School Aged Children with Autism (NVSACA) Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01529580?
This trial is sponsored by Hugo W. Moser Research Institute at Kennedy Krieger, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.